Skip to content

Synergistic Effects of PQQ and PS on Mental and Physical Fatigue: An Effectiveness Study

Synergistic Effects of PQQ and PS on Mental and Physical Fatigue: An Effectiveness Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125172
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-05-25
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Combination Intervention Group (PQQ+PS):Take dietary supplements containing both PQQ and PS.
PQQ-only Intervention Group:Take dietary supplements containing PQQ.
Placebo Group:Take the placebo.

Sponsors

West China School of Public Health and West China Fourth Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Voluntary participants who are required to perform continuous work for a relatively long period of time, nearly 3 months, or who are prone to fatigue, as determined by the Chronic Fatigue Scale, aged 18-45 years.

Exclusion criteria

Exclusion criteria: 1. Individuals with serious cardiovascular or cerebrovascular diseases, severe hepatic, renal, or gastrointestinal disorders, or psychiatric illnesses. 2. Individuals with metabolic syndrome or related chronic conditions, including diabetes mellitus, hypertension, or obesity. 3. Individuals with an allergic predisposition or known hypersensitivity to any component(s) of the investigational product. 4. Individuals with severe insomnia or marked difficulty initiating sleep. 5. Individuals who have consumed substances relevant to the study outcomes within the past month, or used probiotics or antibiotics that could affect result interpretation, or who have had infection, surgery, or metabolic disorders within the past 3 months. 6. Individuals who do not consume the investigational product as specified, or whose data are incomplete and may compromise the evaluation of efficacy or safety.

Design outcomes

Primary

MeasureTime frame
Rating of Perceived Exertion (RPE) Scale;Cognitive performance related to mental fatigue (attention and visual scanning ability);Maximal oxygen uptake (VO2max);Pittsburgh Sleep Quality Index (PSQI) score;Mood State Questionnaire (Profile of Mood States, POMS);Blood lactate, F2-isoprostanes, and brain-derived neurotrophic factor (BDNF);mtDNA copy number, serum lipidomic and metabolomic profiles, and genome-wide DNA methylation profiles related to mitochondrial metabolism;

Secondary

MeasureTime frame
Thyroid hormones, cortisol, dehydroepiandrosterone (DHEA), and testosterone;C-reactive protein (CRP) and inflammatory cytokines;Mental status, sleep, diet, bowel and urinary habits, blood pressure;Routine blood and urine tests, as well as liver and renal function tests;Gut microbiota diversity;

Countries

China

Contacts

Public ContactChen Jinyao

West China School of Public Health and West China Fourth Hospital, Sichuan University

umbrellayy@163.com+86 28 8550 8845

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026